the IDEA (International Duration Evaluation of Adjuvant therapy) trial evaluated the benefit of 3 months vs. 6 months of chemotherapy with either FOLFOX or CAPOX for high- and low-risk stage III colon cancer. It's results establised new standard of care in patients with satge III colon cancer.
.png)
